Steminent Biotherapeutics (ROCO:7729) Days Inventory: 0.00 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:7729 Steminent Biotherapeutics Inc ROCO:7729
11 GF Score
Price NT$72.50
! 4 Warning Signs
View Full Analysis

What is Steminent Biotherapeutics Days Inventory?

Steminent Biotherapeutics ROCO:7729 -2.95% 11 Days Inventory is 0.00 as of Dec. 2025. GuruFocus rates ROCO:7729 with a GF Score™ of 11/100. The stock has 4 warning signs investors should review. Among 638 Biotechnology companies, Steminent Biotherapeutics ranks worse than 97.81% on this metric.

Days Inventory is also known as Days Sales of Inventory (DSI). Steminent Biotherapeutics's Average Total Inventories for the six months ended in Dec. 2025 was NT$12.57 Mil. Steminent Biotherapeutics's Cost of Goods Sold for the six months ended in Dec. 2025 was NT$-0.49 Mil.

The historical rank and industry rank for Steminent Biotherapeutics's Days Inventory or its related term are showing as below:

ROCO:7729' s Days Inventory Range Over the Past 10 Years
Min: 168.69   Med: 790.57   Max: 6290.79
Current: 5755.38

During the past 6 years, Steminent Biotherapeutics's highest Days Inventory was 6290.79. The lowest was 168.69. And the median was 790.57.

ROCO:7729's Days Inventory is ranked worse than
97.81% of 638 companies
in the Biotechnology industry
Industry Median: 183.195 vs ROCO:7729: 5755.38

Steminent Biotherapeutics's Days Inventory declined from Dec. 2024 (1,011.94) to Dec. 2025 (0.00).

Warning Sign:

If a company builds up inventory, it may mean it is having difficulties selling its goods.

Inventory Turnover measures how fast the company turns over its inventory within a year. Steminent Biotherapeutics's Inventory Turnover for the six months ended in Dec. 2025 was -0.04.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.


Steminent Biotherapeutics  (ROCO:7729) Days Inventory Explanation

Days Inventory indicates the liquidity of the inventory. Generally, a lower Days Inventory is preferred as it indicates a shorter duration to clear off the inventory. An increase of the ratio may indicate the company's sales slowed. Similar ratios related to Days Inventory are:

1. Inventory Turnover measures how fast the company turns over its inventory within a year.

Steminent Biotherapeutics's Inventory Turnover for the six months ended in Dec. 2025 is calculated as

2. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

Steminent Biotherapeutics's Inventory to Revenue for the six months ended in Dec. 2025 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

A lot of business are seasonable. It makes more sense to compare Days Inventory from the same period in the previous year instead of from the previous quarter.


Steminent Biotherapeutics Days Inventory Related Terms


Steminent Biotherapeutics Days Inventory Historical Data

* Premium members only.

The historical data trend for Steminent Biotherapeutics's Days Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Steminent Biotherapeutics Days Inventory Chart

Steminent Biotherapeutics Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Inventory
Get a 7-Day Free Trial 991.55 264.78 1,028.72 589.59 6,290.79

Steminent Biotherapeutics Semi-Annual Data
Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Days Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,196.17 503.53 1,011.94 1,585.81 0.00

ROCO:7729 vs VRTX, REGN, ALNY: Days Inventory Comparison

For the Biotechnology subindustry, Steminent Biotherapeutics's Days Inventory, along with its competitors' market caps and Days Inventory data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Steminent Biotherapeutics Days Inventory vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Steminent Biotherapeutics's Days Inventory distribution charts can be found below:

* The bar in red indicates where Steminent Biotherapeutics's Days Inventory falls into.


ROCO:7729
11GF Score
Steminent Biotherapeutics Inc ROCO:7729
Days Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Steminent Biotherapeutics Days Inventory Calculation

Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

Steminent Biotherapeutics's Days Inventory for the fiscal year that ended in Dec. 2025 is calculated as

Days Inventory (A: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (A: Dec. 2024 ) + Total Inventories (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (11.996 + 15.063) / 2 ) / 0.785*365
=13.5295 / 0.785*365
=6,290.79

Steminent Biotherapeutics's Days Inventory for the quarter that ended in Dec. 2025 is calculated as:

Days Inventory (Q: Dec. 2025 )
=Average Total Inventories / Cost of Goods Sold*Days in Period
=( (Total Inventories (Q: Jun. 2025 ) + Total Inventories (Q: Dec. 2025 )) / count ) / Cost of Goods Sold (Q: Dec. 2025 )*Days in Period
=( (10.075 + 15.063) / 2 ) / -0.485*365 / 2
=12.569 / -0.485*365 / 2
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Inventory →
What does a Days Inventory of 0.00 mean?
Steminent Biotherapeutics (ROCO:7729) has a Days Inventory of 0.00 as of Dec. 2025. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Steminent Biotherapeutics and its competitors. Over the past decade, Steminent Biotherapeutics' Days Inventory has ranged from 168.69 to 6,290.79. According to the industry distribution chart, Steminent Biotherapeutics ranks #624 out of 638 companies in the Biotechnology industry, placing it in the top 97.8%.
Is Steminent Biotherapeutics' Days Inventory too high?
Steminent Biotherapeutics' current Days Inventory is 0.00. Over the past 10 years, this metric has ranged from a low of 168.69 to a high of 6,290.79. Based on the distribution chart, Steminent Biotherapeutics ranks #624 out of 638 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Steminent Biotherapeutics has a GF Score™ of 11/100, reflecting its overall financial health beyond just this single metric.
How does Steminent Biotherapeutics' Days Inventory compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Steminent Biotherapeutics ranks #624 out of 638 companies for Days Inventory. This places Steminent Biotherapeutics in the lower half of its industry. The industry median Days Inventory is 183.20. Historically, Steminent Biotherapeutics' own Days Inventory has ranged from 168.69 to 6,290.79 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Inventory for a Biotechnology company?
The median Days Inventory among Biotechnology companies is 183.20, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Days Inventory significantly above this median, while those in the bottom quartile fall well below. However, Days Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Inventory mean?
A high Days Inventory can signal that a stock is expensive relative to its fundamentals. Days inventory represents the average amount of days a company holds inventory before selling it. View historical data on Steminent Biotherapeutics and its competitors. For the Biotechnology industry, the median Days Inventory is 183.20 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Steminent Biotherapeutics's current Days Inventory is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Steminent Biotherapeutics stock overvalued right now?
Steminent Biotherapeutics (ROCO:7729) has a current Days Inventory of 0.00. The current Days Inventory is 0.00. Steminent Biotherapeutics' overall GF Score™ is 11/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Inventory calculated?
Days Inventory is calculated from a company's financial statements. For Steminent Biotherapeutics (ROCO:7729), the current Days Inventory is 0.00 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Steminent Biotherapeutics Business Description

Address No.16,Wenhu Street, Neihu District, Taipei, TWN, 11445
Steminent Biotherapeutics Inc is a international stem cell biopharmaceutical company which has stable and efficient stem cell platform technology, aiming to develop live cell drugs to treat degenerative diseases as well as acute and life-threatening diseases. With its Stemchymal which is proprietary technology platform generating the standardized, clinical grade, allogeneic stem cells isolated from human adipose tissue. It is operated in strict compliance to regulations of Taiwan, the US, and Japan.
11GF Score

Get the complete analysis for ROCO:7729

Days Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$72.50
Price